LYMPHOMA, NON-HODGKINS

Clinical trials for LYMPHOMA, NON-HODGKINS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, NON-HODGKINS trials appear

Sign up with your email to follow new studies for LYMPHOMA, NON-HODGKINS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Supercharged donor cells target stubborn blood cancers

Disease control Completed

This study tested a new cell therapy for adults whose B-cell blood cancers (like leukemia or lymphoma) came back or never fully went away after a donor stem cell transplant. Researchers collected immune cells from the original transplant donor, genetically engineered them to bett…

Matched conditions: LYMPHOMA, NON-HODGKINS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

LYMPHOMA, NON-HODGKINS

Get alerted when new LYMPHOMA, NON-HODGKINS trials appear

Supercharged donor cells target stubborn blood cancers